surmount-1 tirzepatide trial obesity without diabetes after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 Tirzepatide cuts diabetes risk by
Pay in 4 interest-free payments of $6.68 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23

























